Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

General Practitioners Records Are Epidemiological Predictors of Comorbidities: An Analytical Cross-Sectional 10-Year Retrospective Study.

Cavallo P, Pagano S, De Santis M, Capobianco E.

J Clin Med. 2018 Jul 27;7(8). pii: E184. doi: 10.3390/jcm7080184.

2.

Ensemble Modeling Approach Targeting Heterogeneous RNA-Seq data: Application to Melanoma Pseudogenes.

Capobianco E, Valdes C, Sarti S, Jiang Z, Poliseno L, Tsinoremas NF.

Sci Rep. 2017 Dec 11;7(1):17344. doi: 10.1038/s41598-017-17337-7.

3.

Predictive Assessment of Cancer Center Catchment Area from Electronic Health Records.

Salmasi L, Capobianco E.

Front Public Health. 2017 Nov 16;5:303. doi: 10.3389/fpubh.2017.00303. eCollection 2017.

4.

Editorial: Physiology in Extreme Conditions: Adaptations and Unexpected Reactions.

Trivella MG, Capobianco E, L'Abbate A.

Front Physiol. 2017 Sep 29;8:748. doi: 10.3389/fphys.2017.00748. eCollection 2017. No abstract available.

5.

Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment.

Sharma A, Cinti C, Capobianco E.

Front Immunol. 2017 Jul 31;8:918. doi: 10.3389/fimmu.2017.00918. eCollection 2017.

6.

Immuno-Oncology Integrative Networks: Elucidating the Influences of Osteosarcoma Phenotypes.

Sharma A, Capobianco E.

Cancer Inform. 2017 Jul 26;16:1176935117721691. doi: 10.1177/1176935117721691. eCollection 2017. Review.

7.

Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective.

Capobianco E.

Clin Transl Med. 2017 Dec;6(1):23. doi: 10.1186/s40169-017-0155-4. Epub 2017 Jul 25.

8.

The landscape of BRAF transcript and protein variants in human cancer.

Marranci A, Jiang Z, Vitiello M, Guzzolino E, Comelli L, Sarti S, Lubrano S, Franchin C, Echevarría-Vargas I, Tuccoli A, Mercatanti A, Evangelista M, Sportoletti P, Cozza G, Luzi E, Capobianco E, Villanueva J, Arrigoni G, Signore G, Rocchiccioli S, Pitto L, Tsinoremas N, Poliseno L.

Mol Cancer. 2017 Apr 28;16(1):85. doi: 10.1186/s12943-017-0645-4.

9.

Expected Impacts of Connected Multimodal Imaging in Precision Oncology.

Dominietto MD, Capobianco E.

Front Pharmacol. 2016 Nov 29;7:451. eCollection 2016. No abstract available.

10.
11.

Corrigendum: Distinct Transcriptomic Features Are Associated with Transitional and Mature B-Cell Populations in the Mouse Spleen.

Kleiman E, Salyakina D, De Heusch M, Hoek KL, Llanes JM, Castro I, Wright JA, Clark ES, Dykxhoorn DM, Capobianco E, Takeda A, McCormack RM, Podack ER, Renauld JC, Khan WN.

Front Immunol. 2016 Jul 4;7:267. doi: 10.3389/fimmu.2016.00267. eCollection 2016.

12.

Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective.

Gherardini L, Sharma A, Capobianco E, Cinti C.

Curr Pharm Biotechnol. 2016;17(10):856-65. Review.

PMID:
27229488
13.

Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with Demethylation.

El Baroudi M, Cinti C, Capobianco E.

Cancer Inform. 2016 Apr 27;15:45-64. doi: 10.4137/CIN.S31809. eCollection 2016.

14.

Use of instrumental variables in electronic health record-driven models.

Salmasi L, Capobianco E.

Stat Methods Med Res. 2018 Feb;27(2):608-621. doi: 10.1177/0962280216641154. Epub 2016 Apr 7.

PMID:
27055764
15.
16.

Time-course gene profiling and networks in demethylated retinoblastoma cell line.

Malusa F, Taranta M, Zaki N, Cinti C, Capobianco E.

Oncotarget. 2015 Sep 15;6(27):23688-707.

17.

Prognostic models in coronary artery disease: Cox and network approaches.

Mora A, Sicari R, Cortigiani L, Carpeggiani C, Picano E, Capobianco E.

R Soc Open Sci. 2015 Feb 11;2(2):140270. doi: 10.1098/rsos.140270. eCollection 2015 Feb.

18.

Distinct Transcriptomic Features are Associated with Transitional and Mature B-Cell Populations in the Mouse Spleen.

Kleiman E, Salyakina D, De Heusch M, Hoek KL, Llanes JM, Castro I, Wright JA, Clark ES, Dykxhoorn DM, Capobianco E, Takeda A, Renauld JC, Khan WN.

Front Immunol. 2015 Feb 11;6:30. doi: 10.3389/fimmu.2015.00030. eCollection 2015. Erratum in: Front Immunol. 2016;7:267.

19.

Identification of BRAF 3'UTR Isoforms in Melanoma.

Marranci A, Tuccoli A, Vitiello M, Mercoledi E, Sarti S, Lubrano S, Evangelista M, Fogli A, Valdes C, Russo F, Monte MD, Caligo MA, Pellegrini M, Capobianco E, Tsinoremas N, Poliseno L.

J Invest Dermatol. 2015 Jun;135(6):1694-1697. doi: 10.1038/jid.2015.47. Epub 2015 Feb 16. No abstract available.

20.

RNA-Seq Data: A Complexity Journey.

Capobianco E.

Comput Struct Biotechnol J. 2014 Sep 17;11(19):123-30. doi: 10.1016/j.csbj.2014.09.004. eCollection 2014 Sep. Review.

Supplemental Content

Loading ...
Support Center